A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations

A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations

3D printing is a rapidly growing area of interest within pharmaceutical science thanks to its versatility in creating different dose form geometries and drug doses to enable the personalisation of medicines. Research in this area has been dominated by polymer-based materials; however, for poorly wat...

Full description

Bibliographic Details
Main Authors: Bryce W. Barber, Camille Dumont, Philippe Caisse, George P. Simon, Ben J. Boyd
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceutics
Subjects:
lipid
SMEDDS
additive manufacturing
controlled release
Online Access:https://www.mdpi.com/1999-4923/13/12/2107

Similar Items

Similar Items